Current clinical use of polygenic scores will risk exacerbating health disparities
Open accessPreprint — published as 10.1038/s41588-019-0379-x · Paper page
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Polygenic risk scores (PRS) are poised to improve biomedical outcomes via precision medicine. However, the major ethical and scientific challenge surrounding clinical implementation is that they are many-fold more accurate in European ancestry individuals than others. This disparity is an inescapable consequence of Eurocentric genome-wide association study biases. This highlights that—unlike clinical biomarkers and prescription drugs, which may individually work better in some populations but do not ubiquitously perform far better in European populations—clinical uses of PRS today would systematically afford greater improvement to European descent populations. Early diversifying efforts show promise in levelling this vast imbalance, even when non-European sample sizes are considerably smaller than the largest studies to date. To realize the full and equitable potential of PRS, we must prioritize greater diversity in genetic studies and public dissemination of summary statistics to ensure that health disparities are not increased for those already most underserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the emergence of polygenic risk scores derived largely on European populations have been shown to generally perform very poorly on non-European populations27.”
From Predictably unequal: understanding and addressing concerns that algorithmic clinical prediction may increase health disparities (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Self-citationBiological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
Self-citationFry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979
Khera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., Natarajan, P., Lander, E. S., Lubitz, S. A., Ellinor, P. T., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0183-z · Cited by 2,953
A reference panel of 64,976 haplotypes for genotype imputation
the Haplotype Reference Consortium (2016) · Nature Genetics · doi:10.1038/ng.3643 · Cited by 2,836
Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
Self-citation23andMe Research Team, Lee, J. J., COGENT (Cognitive Genomics Consortium), Social Science Genetic Association Consortium, Wedow, R., Okbay, A., Kong, E., Maghzian, O., Zacher, M., Nguyen-Viet, T. A., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0147-3 · Cited by 2,470
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., Junkins, H., McMahon, A., Milano, A., Morales, J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1133 · Cited by 2,161
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., et al. (2010) · Science · doi:10.1126/science.1193032 · Cited by 2,028
Cited by
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
Self-citationAdvances and Open Problems in Federated Learning
Kairouz, P., & McMahan, H. B. (2021) · Foundations and Trends in Machine Learning · doi:10.1561/2200000083 · Cited by 7,772
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2019) · doi:10.1101/531210 · Cited by 1,662
Self-citationA saturated map of common genetic variants associated with human height
Yengo, L., Vedantam, S., Marouli, E., Sidorenko, J., Bartell, E., Sakaue, S., Graff, M., Eliasen, A. U., Jiang, Y., Raghavan, S., et al. (2022) · Nature · doi:10.1038/s41586-022-05275-y · Cited by 825
Self-citationComparative genetic architectures of schizophrenia in East Asian and European populations
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Lam, M., Indonesia Schizophrenia Consortium, Genetic REsearch on schizophreniA neTwork-China and the Netherlands (GREAT-CN), Chen, C.-Y., Li, Z., Martin, A. R., Bryois, J., Ma, X., Gaspar, H., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0512-x · Cited by 655
“Importantly, the applicability of training data from EUR studies to those of non-European ancestry has not been fully assessed, leaving us with an uncertainty as to the biological relevance of the findings made in EUR samples for non-Europeans 21 .”
Self-citationPersonalized Medicine and the Power of Electronic Health Records
Abul-Husn, N. S., & Kenny, E. E. (2019) · Cell · doi:10.1016/j.cell.2019.02.039 · Cited by 355
“Early applications of PRS show greater accuracy of prediction in European populations compared to other populations (Martin et al., 2019).”
Paulus, J. K., & Kent, D. M. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0304-9 · Cited by 274
Predicting Polygenic Risk of Psychiatric Disorders
Martin, A. R., Daly, M. J., Robinson, E. B., Hyman, S. E., & Neale, B. M. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.015 · Cited by 299
Self-citationZheutlin, A. B., Dennis, J., Karlsson Linnér, R., Moscati, A., Restrepo, N., Straub, P., Ruderfer, D., Castro, V. M., Chen, C.-Y., Ge, T., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18091085 · Cited by 223
“It is well known that PRSs calculated from genome-wide association studies (GWASs) performed primarily in one ancestry demonstrate poorer performance in other ancestries as a function of differing linkage disequilibrium (LD) structures with causal variants and lack of diversity on genotyping platforms (23, 24).”
BackgroundMulti-modality machine learning predicting Parkinson’s disease
Makarious, M. B., Leonard, H. L., Vitale, D., Iwaki, H., Sargent, L., Dadu, A., Violich, I., Hutchins, E., Saffo, D., Bandres-Ciga, S., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00288-w · Cited by 158
“Given the quality of data for known protein-coding genes, their relevance in drug development and the robust annotations available we focused on this subset that is more suitable for applications in downstream analyses such as looking at known drug – gene interactions.”
BackgroundWalsh, R., Mazzarotto, F., Whiffin, N., Buchan, R., Midwinter, W., Wilk, A., Li, N., Felkin, L., Ingold, N., Govind, R., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0616-z · Cited by 121
Geographic variation and bias in polygenic scores of complex diseases and traits in Finland
Kerminen, S., Martin, A. R., Koskela, J., Ruotsalainen, S. E., Havulinna, A. S., Surakka, I., Palotie, A., Perola, M., Salomaa, V., Daly, M. J., et al. (2018) · doi:10.1101/485441 · Cited by 115
Self-citationCharacterizing the Genetic Architecture of Parkinson's Disease in Latinos
Loesch, D. P., Horimoto, A. R. V. R., Heilbron, K., Sarihan, E. I., Inca‐Martinez, M., Mason, E., Cornejo‐Olivas, M., Torres, L., Mazzetti, P., Cosentino, C., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26153 · Cited by 107
Waszczuk, M. A., Eaton, N. R., Krueger, R. F., Shackman, A. J., Waldman, I. D., Zald, D. H., Lahey, B. B., Patrick, C. J., Conway, C. C., Ormel, J., et al. (2020) · Journal of Abnormal Psychology · doi:10.1037/abn0000486 · Cited by 119
“Likewise, molecular psychiatric genetic research is limited by its heavy focus on populations of European ancestry (Martin et al., 2018; Torkamani, Wineinger, & Topol, 2018).”
Palk, A. C., Dalvie, S., de Vries, J., Martin, A. R., & Stein, D. J. (2019) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/s13010-019-0073-8 · Cited by 96
Self-citationIs population structure in the genetic biobank era irrelevant, a challenge, or an opportunity?
Lawson, D. J., Davies, N. M., Haworth, S., Ashraf, B., Howe, L., Crawford, A., Hemani, G., Davey Smith, G., & Timpson, N. J. (2020) · Human Genetics · doi:10.1007/s00439-019-02014-8 · Cited by 109
Human Disease Variation in the Light of Population Genomics
Prohaska, A., Racimo, F., Schork, A. J., Sikora, M., Stern, A. J., Ilardo, M. A., Allentoft, M. E., Folkersen, L., Buil, A., Moreno-Mayar, J. V., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.052 · Cited by 123
A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women
Shieh, Y., Fejerman, L., Lott, P. C., Marker, K. M., Sawyer, S. D., Hu, D., Huntsman, S., Torres, J., Echeverry, M., Bohórquez, M., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz174 · Cited by 94
“performance in non-Europeans, they suggest that PRS constructed using European SNP summary statistics (effect size, allele frequency) typically perform worse in non-European populations [14, 15].”
Dai, C. L., Vazifeh, M. M., Yeang, C.-H., Tachet, R., Wells, R., Vilar, M., Daly, M. J., Ratti, C., & Martin, A. R. (2019) · bioRxiv · doi:10.1101/577411 · Cited by 53
Self-citationJoo, Y. Y., Actkins, K., Pacheco, J., et al. (2019) · bioRxiv · doi:10.1101/714113 · Cited by 47
Edenberg, H. J., Gelernter, J. E., & Agrawal, A. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1008-1 · Cited by 70
Dennis, J. K., Sealock, J., Levinson, R. T., Farber‐Eger, E. H., Franco, J. A., Fong, S., Straub, P., Hucks, D., Song, W., Linton, M. F., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0614-y · Cited by 57
Machine learning applications for therapeutic tasks with genomics data
Huang, K., Xiao, C., Glass, L. M., Critchlow, C. W., Gibson, G. C., & Sun, J. (2021) · Patterns · doi:10.1016/j.patter.2021.100328 · Cited by 52
Genetic Architecture and Molecular Neuropathology of Human Cocaine Addiction
Huggett, S. B., & Stallings, M. C. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2879-19.2020 · Cited by 54
“Another important caveat of GWAS research is that most findings are based on individuals of European ancestry/ethnicity (Martin et al., 2019), highlighting a priority to investigate the genetic basis of traits among non-Europeans.”
BackgroundAcosta, H., Kantojärvi, K., Hashempour, N., Pelto, J., Scheinin, N. M., Lehtola, S. J., Lewis, J. D., Fonov, V. S., Collins, D. L., Evans, A., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa158 · Cited by 34
“Accordingly, there is consistent evidence that polygenic risk scores derived from a predominantly European sample predict individual risk with higher accuracy in Europeans than in nonEuropeans (Martin et al. 2018).”
Kolobkov, D. S., Sharma, S. M., Медведев, А. В., Lebedev, M., Kosaretskiy, E., & Vakhitov, R. (2024) · Frontiers in Big Data · doi:10.3389/fdata.2024.1266031 · Cited by 46
“Currently, the vast majority of healthcare data comes from people of European descent which makes models trained on this data biased towards Europeans, adding to the healthcare inequality of people around the world [58] [59].”
BackgroundNolan, J. J., & Ormondroyd, E. (2023) · Clinical Genetics · doi:10.1111/cge.14332 · Cited by 36
Advances and Applications of Polygenic Scores for Coronary Artery Disease
Patel, A. P., & Khera, A. V. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-112629 · Cited by 41
“A key equity issue has arisen in that although current scores are associated with increased risk across different ancestries, they have diminished predictive power in non-European ancestries (13, 97-99).”
Yengo, L., Vedantam, S., Marouli, E., Sidorenko, J., Bartell, E., Sakaue, S., Graff, M., Eliasen, A. U., Jiang, Y., Raghavan, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.07.475305 · Cited by 18
Self-citationMcGuinness, M., Fassi, E., Wang, C., Hacking, C. C., & Ellis, V. (2020) · Journal of Genetic Counseling · doi:10.1002/jgc4.1347 · Cited by 26
“Prior research has suggested that ordering PRS has the potential to exacerbate healthcare disparities (Martin et al., 2019).”
BackgroundGenetically regulated gene expression underlies lipid traits in Hispanic cohorts
Andaleon, A., Mogil, L. S., & Wheeler, H. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220827 · Cited by 20
Wetherill, L. F., Lai, D., Johnson, E. C., Anokhin, A. P., Bauer, L. O., Bucholz, K. K., Dick, D. M., Hariri, A. R., HESSELBROCK, V. M., Kamarajan, C., et al. (2019) · Genes Brain & Behavior · doi:10.1111/gbb.12580 · Cited by 25
Hu, S.-L., Ferreira, L. A. F., Shi, S., Hellenthal, G., Marchini, J., Lawson, D., & Myers, S. (2023) · bioRxiv · doi:10.1101/2023.08.08.552281 · Cited by 18
Rohatgi, A. K., Anand, S. S., Gadgil, M. D., Gujral, U. P., Jain, S. S., Javed, Z., Jha, M. K., Joshi, P. H., Manubolu, V. S., Nasir, K., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101000 · Cited by 22
“Although SAs comprise nearly a quarter of the world population, they make up approximately 1.3 % of available GWAS studies to date [109].”
InfluentialMooney, M. A., Hermosillo, R., Feczko, E., et al. (2021) · Journal of Neuroscience · doi:10.1101/2021.11.16.21266121 · Cited by 16
“In addition, access to more diverse discovery cohorts for PRS are sorely needed to address the generalizability of PRS effects (Martin et al. 2019).”
BackgroundHow robust are cross-population signatures of polygenic adaptation in humans?
Refoyo-Martínez, A., Liu, S.-Y., Jørgensen, A. M., et al. (2020) · bioRxiv · doi:10.1101/2020.07.13.200030 · Cited by 16
Self-citationTanksley, P. T., Brislin, S. J., Wertz, J., de Vlaming, R., Courchesne‐Krak, N. S., Mallard, T. T., Raffington, L., Linnér, R. K., Koellinger, P., Palmer, A. A., et al. (2024) · Clinical Psychological Science · doi:10.1177/21677026241260260 · Cited by 30
“…children was appropriate for the current analysis because the GWAS of externalizing behavior was conducted in European-ancestry individuals, and PGIs (particularly those for complex behavioral traits) have low portability across ancestry groups (Martin et al., 2019; Privé et al., 2022).”
BackgroundGenetic risk scores and dementia risk across different ethnic groups in UK Biobank
Mukadam, N., Giannakopoulou, O., Bass, N., Kuchenbaecker, K., & McQuillin, A. (2022) · PLOS ONE · doi:10.1371/journal.pone.0277378 · Cited by 14
“Using GRS from GWAS conducted in European origin samples to predict disease status in diverse ethnic groups in general could be less accurate than predicting phenotypes in those of European origin [13] due to differences in allele frequencies and patterns of linkage disequilibrium, potentially leading to widening heal…”
MethodThe Evolving Field of Genetic Epidemiology: From Familial Aggregation to Genomic Sequencing
Duggal, P., Ladd‐Acosta, C., Ray, D., & Beaty, T. H. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz193 · Cited by 28
Khodasevich, D., Gladish, N., Daredia, S., Bozack, A. K., Shen, H., Nwanaji‐Enwerem, J. C., Needham, B. L., Rehkopf, D. H., & Cárdenas, A. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01864-6 · Cited by 13
Farooqi, R., Kooner, J. S., & Zhang, W. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01584-x · Cited by 12
WEDEKIND, L. E., Mahajan, A., Hsueh, W., Chen, P., Olaiya, M. T., Kobes, S., Sinha, M., Baier, L. J., Knowler, W. C., McCarthy, M. I., et al. (2021) · Diabetologia · doi:10.1007/s00125-023-05870-2 · Cited by 18
“in a more closely matched ancestry group would perform better than one from a different ancestry group, if GWAS sample sizes are equal [34], but PSs derived in a large”
BackgroundRabinowitz, J. A., Campos, A., Benjet, C., et al. (2020) · medRxiv · doi:10.1101/2020.05.31.20118711 · Cited by 12
Interventions to Reduce Ethnic and Racial Disparities in Dyslipidemia Management
Chang, A. Y., Abou-Arraj, N. E., & Rodríguez, F. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0725-4 · Cited by 12
Zheutlin, A., Dennis, J. K., Linnér, R., et al. (2018) · bioRxiv · doi:10.1101/421164 · Cited by 12
Polygenic risk prediction and SNCA haplotype analysis in a Latino Parkinson's disease cohort
Loesch, D. P., Horimoto, A. R. V. R., Sarihan, E. I., Inca‐Martinez, M., Mason, E., Cornejo‐Olivas, M., Torres, L., Mazzetti, P., Cosentino, C., Sarapura‐Castro, E. H., et al. (2022) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2022.06.010 · Cited by 11
From Genotype to Phenotype: Polygenic Prediction of Complex Human Traits
Raben, T. G., Lello, L., Widén, E., & Hsu, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2205-6_15 · Cited by 15
“The implications of this skewed focus are serious as the majority of the world population, including minorities within countries of predominantly European descent, are left out from these new advancements in health care [68].”
BackgroundBiobank-scale methods and projections for sparse polygenic prediction from machine learning
Raben, T. G., Lello, L., Widén, E., & Hsu, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-37580-5 · Cited by 15
Lebovitch, D. S., Johnson, J., Duenas, H. R., & Huckins, L. M. (2021) · medRxiv · doi:10.1101/2021.01.25.21249615 · Cited by 7
The color of normal: How a Eurocentric focus erases pigmentation complexity
Norton, H. L. (2021) · American Journal of Human Biology · doi:10.1002/ajhb.23554 · Cited by 13
“The majority of the markers evaluated for these panels were identified in European-focused investigations like the admixture and GWAS studies described above, although some were drawn from population-specific GWAS in South Asian populations (eg, Stokowski et al., 2007) or more globally diverse population samples from…”
BackgroundInfluentialInstability of high polygenic risk classification and mitigation by integrative scoring
Misra, A., Truong, B., Urbut, S., Sui, Y., Fahed, A., Smoller, J., Patel, A. P., & Natarajan, P. (2024) · medRxiv · doi:10.1101/2024.07.24.24310897 · Cited by 11
“23 The better accuracy and inter-PRSMix_AOI ₙ consistency make it an ideal framework for incorporation into clinical workflows for PRS reporting and updating.”
Methodde Hemptinne, M., & Posthuma, D. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01333-4 · Cited by 19
Mooney, M. A., Neighbor, C., Karalunas, S. L., Dieckmann, N. F., Nikolas, M. A., Nousen, E. K., Tipsord, J. M., Song, X. B., & Nigg, J. T. (2022) · Clinical Psychological Science · doi:10.1177/21677026221120236 · Cited by 20
“…polygenic risk scores or individual variants) still have limited utility in terms of clinical diagnosis or prognosis (Martin, Daly, et al., 2019; Martin, Kanai, et al., 2019; Palk et al., 2019; Ronald et al., 2021), although they may be added to a diagnostic algorithm in some form in the…”
BackgroundGenomics-Enhanced Cancer Risk Prediction for Personalized LLM-Driven Healthcare Recommender Systems
Lu, K., Lü, J., Xu, H., Guo, K., Zhang, Q., Lin, H., Grosser, M., Zhang, Y., & Zhang, G. (2025) · ACM Transactions on Information Systems · doi:10.1145/3745022 · Cited by 11
“In particular, the use of SNPs data has drastically improved predictions over an individual’s cancer susceptibility, especially those models that also incorporate PRS [7].”
Morozova, A. Y., Ushakova, V. M., Pavlova, O., Bairamova, S., Andriushchenko, N., Ochneva, A., Abramova, O. V., Zorkina, Y., Spektor, V. A., Гадисов, Т. Г., et al. (2024) · Genes · doi:10.3390/genes15020240 · Cited by 11
“Importantly, the applicability of research data from European population studies to those of non-European ancestry has not been fully assessed, leading to uncertainty as to the biological relevance of the discoveries made in European samples to non-Europeans [40].”
Lello, L., Hsu, M., Widén, E., & Raben, T. G. (2023) · Scientific Reports · doi:10.1038/s41598-023-27561-z · Cited by 14
Khan, A. T., Gogarten, S., McHugh, C. P., Stilp, A., Sofer, T., Bowers, M., Wong, Q., Cupples, L., Hidalgo, B. A., Johnson, A. D., et al. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2108.07858 · Cited by 8
Vrantsidis, D. M., Wuest, V., & Wiebe, S. A. (2022) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-022-00387-3 · Cited by 8
“First, the predictive validity of polygenic scores decreases as much as five-fold when predicting outcomes in individuals from populations that differ from the population used to derive the weights (Martin et al., 2019).”
BackgroundPreventive Cardiology and Risk Assessment: Beyond LDL
Goyal, A., & Cho, L. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00876-2 · Cited by 10
Asgari, S., Luo, Y., Belbin, G. M., Bartell, E., Calderon, R. I., Slowikowski, K., Contreras, C. C., Yataco, R. M., Galea, J. T., Jiménez, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/561241 · Cited by 5
McGee, E. E., Zeleznik, O. A., Balasubramanian, R., Hu, J., ROSNER, B. A., Wactawski‐Wende, J., Clish, C. B., Ávila-Pacheco, J., Willett, W. C., Rexrode, K. M., et al. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01111-x · Cited by 8
“While efforts are underway in other ‘omic fields to identify racial inequalities and address the lack of racial diversity [33–35], little work has been done in metabolomics.”
Rabinowitz, J. A., Kuo, S. I., Domingue, B. W., Smart, M. J., Felder, W., Benke, K. S., Maher, B. S., Ialongo, N. S., & Uhl, G. R. (2019) · Behavior Genetics · doi:10.1007/s10519-019-09982-7 · Cited by 9
Muse, E., Chen, S.-F., Liu, S., et al. (2021) · medRxiv · doi:10.1101/2021.04.26.21256141 · Cited by 5
Does salivary telomere length explain race/ethnic differences in aging?
Brown, L., García, C., & Ailshire, J. (2020) · Biodemography and Social Biology · doi:10.1080/19485565.2020.1798736 · Cited by 7
“Molecular based biomarkers and social genomic measures like STL and PGRs may not be similarly predictive in small homogenous samples and diverse population based surveys (Martin et al. 2018).”
Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers
Pouget, J. G., Giratallah, H., Langlois, A. W. R., El‐Boraie, A., Lerman, C. E., Knight, J., Cox, L. S., Nollen, N. L., Ahluwalia, J. S., Benner, C., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02703-5 · Cited by 6
“To date, most genetic studies of NMR have been undertaken in European ancestry smokers, and the genetic architecture of NMR in non-European smokers remains only partially understood, contributing to potential health disparities [13].”
InfluentialDennis, J. K., Sealock, J., Levinson, R. T., Farber‐Eger, E. H., Franco, J. A., Fong, S., Straub, P., Hucks, D., Linton, M. F., Song, W., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/512541 · Cited by 7
Alexandre, A., Maria, K. D., Philipp, K., Mauro, P., Maddalena, Q., Barbara, R., & Guy, V. D. E. (2019) · doi:10.2760/948992 · Cited by 4
“This could increase already existing differences in health and life quality further (Martin et al., 2019).”
BackgroundInfluentialChun, M. Y., Jung, S., Choe, J., Lee, S., Kim, H., Son, H. J., Choi, Y., Cho, M., Kim, B., Jang, H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70660 · Cited by 5
Systematic exploration of a decade of publications on psychiatric genetics in Latin America
Garro, D., Picado-Martínez, M. J., Espinoza‐Campos, E., Ugalde‐Araya, D., Macaya, G., Raventós, H., & Chavarría‐Soley, G. (2023) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32960 · Cited by 3
“…in large epidemiological genetic studies; this problem stems from the fact that the resources needed to fund studies with tens of thousands to hundreds of thousands individuals are only available in well-developed countries (Fonseca et al., 2020; Martin et al., 2019; R. E. Peterson et al., 2019).”
BackgroundMack, T., Sanchez‐Roige, S., & Davis, L. K. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02251-y · Cited by 5
“Additionally, this study focused on individuals of European ancestry leaving a research gap that needs to be filled with studies from diverse populations [46, 47].”
BackgroundEstimating genetic correlation jointly using individual-level and summary-level GWAS data
Zhang, Y., Jiang, W., Shen, J., Cheng, Y., Ye, Y., Lu, Q., & Zhao, H. (2026) · Nature Communications · doi:10.1038/s41467-026-76693-z · Cited by 3
“On one hand, it is inappropriate to generalize the fi ndings in the European population to the non-European population 37,38 .”
Lowe, C. L., Gomez‐Stafford, J., & Martschenko, D. O. (2024) · Journal of Genetic Counseling · doi:10.1002/jgc4.1976 · Cited by 2
“Imprecise risk assessment for underrepresented patient populations, potentially exacerbating health disparities (Martin et al., 2019) It may be challenging to interpret clinical polygenic scores for admixed patients when they are reported with reference to single-race categories.”
Coombes, B., Landi, I., Choi, K., Singh, K., Fennessy, B., Gao, Y.-N., Jenkins, G., Batzler, A., Pendegraft, R., Núñez, N., et al. (2022) · medRxiv · doi:10.1101/2022.04.11.22273720 · Cited by 2
Mooney, M. A., Neighbor, C., Karalunas, S. L., Dieckmann, N. F., Nikolas, M. A., Nousen, E. K., Tipsord, J. M., Song, X. B., & Nigg, J. T. (2021) · medRxiv · doi:10.1101/2021.12.23.21268330 · Cited by 5
“…polygenic risk scores or individual variants) still have little utility in terms of clinical diagnosis/prognosis (Ronald, Bode, and Polderman 2021; Martin, Kanai, et al. 2019; Martin, Daly, et al. 2019; Palk et al. 2019), although they may before long be added to a diagnostic algorithm in some…”
BackgroundGenetic Diversity in Chimpanzee Transcriptomics Does Not Represent Wild Populations
Shukla, N., Shaban, B., & Romero, I. G. (2021) · Genome Biology and Evolution · doi:10.1093/gbe/evab247 · Cited by 3
Liu, Y., Chang, L., Yang, H., Li, J., Chen, Y., Hung, S.-C., & Chen, I. (2025) · Cancer Medicine · doi:10.1002/cam4.71395 · Cited by 2
“…criteria: (1) demonstrate established analytic validity in external samples not used for score development, and (2) provide the necessary information to calculate the score, thereby facilitating a more objective assessment of the PGS's accuracy and enabling external validation of its validity [39].”
Alzheimer's disease in the Kingdom of Saudi Arabia: Current perspectives and genetic insights
Alharbi, A. A., Alatwi, H. E., Albulaihe, H. M., & Algarzae, N. K. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251316122 · Cited by 2
“28,29 The prevalence of AD in Arab countries has not been accurately evaluated in comprehensive epidemiological studies.”
Tanksley, P., Brislin, S. J., Wertz, J., de Vlaming, R., Courchesne-Krak, N. S., Mallard, T., Raffington, L., Linnér, R. K., Koellinger, P., Palmer, A., et al. (2023) · medRxiv · doi:10.1101/2023.05.31.23290802 · Cited by 4
Lello, L., Hsu, M., Widen, E., et al. (2022) · medRxiv · doi:10.1101/2022.09.17.22280057 · Cited by 1
Emami, N. C., Cavazos, T. B., Rashkin, S. R., et al. (2020) · bioRxiv · doi:10.1101/2020.02.12.929463 · Cited by 1
“European descent [6], can be biased by genetic drift between ethnic groups [28], and could potentially widen existing health disparities [29].”
BackgroundEvaluation of phenotyping errors on polygenic risk score predictionsPreprint
Li, R., Tong, J., Duan, R., Chen, Y., & Moore, J. H. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/724534 · Cited by 1
Timpson, N. J., & Dudbridge, F. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14870.1 · Cited by 1
“A more comprehensive summary of MZ twin concordances is presented in reference (3) and reference (4) gives the mathematical reasoning of why this is so: If liability to disease is continuous, and disease status is diagnosed after a threshold has been passed, the probability of discordance in MZ twins depends on the he…”
BackgroundKato, M., Mizuno, F., Taniguchi, Y., Kondo, O., Matsushita, M., Matsushita, T., Saso, A., Yoneda, M., Kurosaki, K., Wang, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.14.694187
“Moreover, the genetic characteristics of the Jomon people, particularly those related to complex traits, have not yet been investigated with sufficient consideration of inter-individual variation (Martin et al., 2019).”
Taylor, K., Huerta‐Chagoya, A., Wang, X., Vora, M., Li, J., Türk, L., Heng, T. H., Kim, J., Moreno‐Estrada, A., Tusié‐Luna, T., et al. (2025) · medRxiv · doi:10.1101/2025.11.24.25340878 · Cited by 1
“Overrepresentation by European populations can lead to PRSs that are less accurate for non-European populations, exacerbating existing public health disparities 45 .”
Esmundo, S., Cáceres, N. A., Ricker, C. N., Idos, G., Lorona, N. C., Castellon‐Lopez, Y., Schmit, S. L., Meade, C. D., Gwede, C. K., Nguyen, N. T., et al. (2025) · Journal of Genetic Counseling · doi:10.1002/jgc4.70135
“Accurate genetic risk prediction requires not just technical improvements in PRS testing but also careful consideration of how these tools are implemented in various clinical settings (Kachuri et al., 2024; Martin et al., 2019 ).”
Canter, C., Meagher, K. M., Cadigan, R. J., Koopmann, A., Watson, S., Kucmanic, M., Ban, S. W., Tran, T. N., Hromcenco, M., Foley, K., et al. (2025) · AJOB Empirical Bioethics · doi:10.1080/23294515.2025.2576839 · Cited by 3
“PGIs are developed from genome-wide association studies (GWASs) which leverage genotype and phenotype data from large databases such as biobanks (Martin et al. 2019; Loos 2020).”
MAP-PRS: Multi-Ancestry Portfolio-Based Polygenic Risk ScoresPreprint
Thakur, L. S., Singh, N., & Bharj, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.15.682516 · Cited by 1
Clark, C. J., Lu, Z., Anderson, N., Li, Y., Park, J. E., Love, M. I., Marcotte, E., de Smith, A. J., & Spector, L. G. (2025) · medRxiv · doi:10.1101/2025.10.02.25336752
“Although genomic PRS developed in individuals with mainly European ancestry have been shown to have reduced predictive ability in non-European populations, 98 the conventional PRS for ALL based on GWAS SNPs and used in this study has been shown to perform similarly across ancestry groups.”
Metadata
- Authors
- Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J.
- Affiliations
- Broad Institute (US)
- Kyoto University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- Corresponding author
- Martin, Alicia R.
- ORCID
- Venue
- Nature Genetics
- Publisher
- openRxiv
- Published
- 2018-10-11
- Volume
- 51
- Issue
- 4
- Pages
- 584-591
- ISSN
- 1061-4036 (ISSN-L)
- PMC
- PMC6563838
- OpenAlex
- W2932671560
- Cited by
- 2,813
- References
- 77
- Citations by year
- 2026: 446 · 2025: 412 · 2024: 385 · 2023: 445 · 2022: 408 · 2021: 390 · 2020: 227 · 2019: 93 · 2018: 3
- FWCI
- 37.52
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by
- Locations
- Nature Genetics (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Japan Agency for Medical Research and Development
- Masason Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- National Institutes of Health (31063)
- National Institute of Mental Health (K99MH117229)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Topics
- Social Sciences › Anthropology › Race, Genetics, and Society
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Forensic and Genetic Research
- Keywords
- polygenic risk score, health disparities, ancestry bias, genome-wide association study, precision medicine, underrepresented groups
- MeSH terms
- Genotype, Humans, Risk Factors, Genetic Predisposition to Disease, Multifactorial Inheritance, White People, Healthcare Disparities, Genome-Wide Association Study, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.